Asthma and COVID-19: What do we know now

The COVID-19 pandemic has presented challenges in symptomology identification, diagnosis, management and follow-up in common respiratory diseases, and in particular asthma. Research is rapidly ongoing to try and understand how the SARS-CoV-2 virus affects individuals with asthma, as well as, how und...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine Vol. 14; p. 1179548420966242
Main Authors:	Hughes-Visentin, Alexzandra, Paul, Anthea B Mahesan
Format:	Book Review Journal Article
Language:	English
Published:	London, England SAGE Publications 2020 Sage Publications Ltd SAGE Publishing
Subjects:	Asthma Coronaviruses COVID-19 Review Severe acute respiratory syndrome coronavirus 2 COVID-19 treatment asthma biologics corticosteroids respiratory
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The COVID-19 pandemic has presented challenges in symptomology identification, diagnosis, management and follow-up in common respiratory diseases, and in particular asthma. Research is rapidly ongoing to try and understand how the SARS-CoV-2 virus affects individuals with asthma, as well as, how underlying asthma affects Covid-19 risk, symptomology and prognosis. In light of this unique medical challenge, clinicians are faced with case-by-case based decisions to implement or continue current asthma therapy. This review will discuss the current literature regarding asthma and COVID-19 based on best available evidence at this time (See box 1).
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1
ISSN:	1179-5484 1179-5484
DOI:	10.1177/1179548420966242